Suchergebnisse - "Wong, Florence"

PubPharm (149)

61

M1711 Are the Characteristics of Patients with Cirrhosis and Decompensation Changing? a Study Comparing Two Time Periods

enthalten in: Gastroenterology | 2009

von Rabie, R. | Renner, E. | Wong, F.

62

The 'Gerstmann's Syndrome' of transjugular intrahepatic portosystemic shunt: should it be the left or should it be the right

enthalten in: Liver international | 2009

von Wong, F.

63

Erratum: The Use of E-A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt

enthalten in: The American journal of gastroenterology | 2009

von Rabie, R. | Cazzaniga, M. | Salerno, F. | +1

64

M1711 Are the Characteristics of Patients with Cirrhosis and Decompensation Changing? a Study Comparing Two Time Periods

enthalten in: Gastroenterology | 2009

von Rabie, R. | Renner, E. | Wong, F.

65

The Use of E/A Ratio as a Predictor of Outcome in Cirrhotic Patients Treated With Transjugular Intrahepatic Portosystemic Shunt

enthalten in: The American journal of gastroenterology | 2009

von Rabie, R. | Cazzaniga, M. | Salerno, F. | +1

66

Publisher's Statement

enthalten in: Radwaste solutions | 2009

von Draut, A. | Hart, P. | Lorenson, T. | +4

67

Hepatorenal syndrome: Current management

enthalten in: Current gastroenterology reports | 2008

von Wong, F.

68

Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndromeFNR HREF="fn1">FN ID="fn1">Potential conflict of interest: Nothing to report.FNR HREF="fn2">FN ID="fn2">Part of this work was undertaken at University College London Hospitals-University College London, which received a proportion of its funding from the United Kingdom Department of Health through the National Institute for Health Research Biomedical Research Centres. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health.

enthalten in: Hepatology | 2008

von Wong, F. | Moore, K. | Dingemanse, J. | +1

69

Authors' response

enthalten in: Gut | 2008

von Salerno, F. | Gerbes, A. | Gines, P. | +2

70

Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trialClinical Trial Registration Number: NCT00501722.

enthalten in: Hepatology | 2008

von Ginès, P. | Wong, F. | Watson, H. | +3